Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.

[1]  H. Fibiger,et al.  Functional evidence for subsensitivity of noradrenergic alpha 2 receptors after chronic desipramine treatment. , 1980, Life sciences.

[2]  L. Chiodo,et al.  Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment , 1980, Nature.

[3]  M. Rehavi,et al.  Amitriptyline: Long-term treatment elevates α-adrenergic and muscarinic receptor binding in mouse brain , 1980, Brain Research.

[4]  A. Maggi,et al.  Differential effects of antidepressant treatment on brain monoaminergic receptors. , 1980, European journal of pharmacology.

[5]  Y. Nomura,et al.  Modifications of central 5-hydroxytryptamine binding sites in synaptic membranes from rat brain after long-term administration of tricyclic antidepressants. , 1979, European journal of pharmacology.

[6]  G. Gessa,et al.  Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. , 1979, Life sciences.

[7]  T. Usdin,et al.  Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha-receptor mediation. , 1978, Science.

[8]  P. Molinoff,et al.  Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. , 1978, The Journal of pharmacology and experimental therapeutics.

[9]  C. Smith,et al.  Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment. , 1978, Science.

[10]  R. Wise.  Catecholamine theories of reward: A critical review , 1978, Brain Research.

[11]  J. Mendels,et al.  Influence of acute and chronic treatment with desmethylimipramine on catecholamine effects in the rat. , 1978, The Journal of pharmacology and experimental therapeutics.

[12]  F. Sulser.  Functional Aspects of the Norepinephrine Receptor Coupled Adenylate Cyclase System in the Limbic Forebrain and its Modification by Drugs which Precipitate or Alleviate Depression: Molecular Approaches to an Understanding of Affective Disorders , 1978, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

[13]  Schmidt Mj,et al.  Norepinephrine-stimulated cyclic AMP accumulation in brain slices in vitro after serotonin depletion or chronic administration of selective amine reuptake inhibitors. , 1977 .

[14]  L. S. Kung,et al.  Development of β-adrenergic receptor subsensitivity by antidepressants , 1977, Nature.

[15]  S. Snyder,et al.  Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.

[16]  S. Snyder,et al.  Antidepressants and the muscarinic acetylcholine receptor. , 1977, Archives of general psychiatry.

[17]  J. Schultz.  Psychoactive drug effects on a system which generates cyclic AMP in brain , 1976, Nature.

[18]  Laurence R. Meyerson,et al.  Neuroamine-derived alkaloids: substrate-preferred inhibitors of rat brain monoamine oxidase in vitro. , 1976, Biochemical pharmacology.

[19]  S. Iversen,et al.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum , 1975, Brain Research.

[20]  J. Vaage,et al.  The pulmonary vasoconstrictor response to hypoxia: effects of inhibitors of prostaglandin biosynthesis. , 1975, Acta physiologica Scandinavica.

[21]  H. Fibiger,et al.  Ascending catecholamine pathways and amphetamine-induced locomotor activity: Importance of dopamine and apparent non-involvement of norepinephrine , 1975, Brain Research.

[22]  S. Iversen,et al.  The pharmacological and anatomical substrates of the amphetamine response in the rat , 1975, Brain Research.

[23]  H. Fibiger,et al.  Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra. , 1974, European journal of pharmacology.

[24]  D. Wong,et al.  A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. , 1974, Life sciences.

[25]  Hedley Aj.  Letter: Smoking and doctors. , 1973, Lancet.

[26]  W. Weiner,et al.  Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior. , 1972, Journal of the neurological sciences.

[27]  V. Březinová,et al.  On the Slowness of Action of Tricyclic Antidepressant Drugs , 1972, British Journal of Psychiatry.

[28]  U. Ungerstedt.  Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[29]  J. Schildkraut.  Neuropsychopharmacology and the Affective Disorders , 1969 .

[30]  T. Lewander.  Influence of various psychoactive drugs on the in vivo metabolism of d-amphetamine in the rat. , 1969, European journal of pharmacology.

[31]  T. Hökfelt,et al.  Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. , 1969, European journal of pharmacology.

[32]  G. Oxenkrug,et al.  Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. , 1969, Lancet.

[33]  C. Morpurgo.  Interaction of imipramine and desmethylimipramine with tremorine and oxotremorine in mice. , 1967, Life sciences.

[34]  F. Sulser,et al.  On the mechanism of amphetamine potentiation by desipramine (DMI) , 1966 .

[35]  L. Iversen,et al.  Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. , 1966, The Journal of pharmacology and experimental therapeutics.

[36]  J. Bevan,et al.  Antagonism of lobeline by ganglion-blocking agents at afferent nerve endings. , 1966, The Journal of pharmacology and experimental therapeutics.

[37]  M. Goldstein,et al.  The conversion in vivo of D-amphetamine to (+)-p-hydroxynorephedrine. , 1965, Biochimica et biophysica acta.

[38]  L. Whitby,et al.  Effect of Psychotropic Drugs on the Uptake of H3-Norepinephrine by Tissues , 1961, Science.

[39]  H. Fibiger.  MECHANISMS: A CRITICAL REVIEW OF THE CATECHOLAMINE THEORY , 1978 .

[40]  S. Snyder,et al.  Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. , 1971, Molecular pharmacology.